Research
-
New treatment for Crohn’s disease
A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease. Read MoreMar 22, 2016
-
Putting schizophrenia to bed
A new compound developed at Vanderbilt treats multiple symptoms of schizophrenia in an animal model, without causing sedation. Read MoreMar 21, 2016
-
Slamming Latinos motivates many of them to register and vote
Presidential candidate Donald Trump may be inadvertently tapping into a phenomenon that is energizing U.S. Latinos against him when he talks of sending illegal immigrants home and building a wall blocking off Mexico. Read MoreMar 17, 2016
-
Wernke, Frederick visit D.C. to advocate for humanities funding
Mona Frederick, director of the Robert Penn Warren Center for the Humanities, and Steve Wernke, associate professor of anthropology, recently attended the National Humanities Alliance’s annual meeting and advocacy day in Washington, D.C. and met with members of Tennessee’s congressional delegation. Read MoreMar 17, 2016
-
ROCKs and cancer invasion
The rigidity of the microenvironment around cancer cells drives invasive behavior through distinct ROCK signaling pathways, which could guide the development of specific anti-invasive therapies. Read MoreMar 17, 2016
-
Study suggests cancer’s ‘clock’ can be rewound
Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented. Read MoreMar 17, 2016
-
Vanderbilt partners with LaunchTN to support student startup pitch competitions
Five Vanderbilt University student startup pitch competitions have won funding from Launch Tennessee as part of its Statewide University Venture Challenge, designed to support entrepreneurship among college students. Read MoreMar 17, 2016
-
Study explores gene’s role in protecting HIV patients from TB
An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12. Read MoreMar 17, 2016
-
Study explores carb-loading’s effect on heart
Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found. Read MoreMar 17, 2016
-
Vanderbilt to host conference on historic and present-day conflicts in Colombia
To mark Colombia's historic peace accord with rebels, scholars from around the world will gather at Vanderbilt to consider the history of conflict in Colombia and its prospects for peace moving forward. Read MoreMar 16, 2016
-
Nobel Prize-winning economist will deliver Steine Lecture March 22
Alvin E. Roth, who shared the 2012 Nobel Memorial Prize in Economics, will discuss “Who Gets What and Why: The Economics of Matching and Market Design" March 22. Roth is responsible for re-designing the National Resident Matching Program, through which approximately 20,000 doctors a year find their first employment as residents at American hospitals. Read MoreMar 16, 2016
-
Research Internet to expand tenfold
As the result of a joint faculty and staff project, Vanderbilt’s digital pipeline to the outside world will expand tenfold in the next few months, making it much easier for campus researchers to send and receive the increasingly large data files characteristic of cutting-edge scientific and medical research. Read MoreMar 14, 2016
-
The Conversation: Organizing a student protest? Have a look at 1970s Germany
Christoph Zeller, associate professor of German, writes: "Looking back at the protest movement in Germany reveals parallels that help to understand the present." Read MoreMar 11, 2016
-
FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use
The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States. Read MoreMar 10, 2016
-
IOM study calls for better evidence for biomarker tests
Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine. Read MoreMar 10, 2016
-
Pioneering diabetes researcher Park celebrates 100th birthday
Pioneering Vanderbilt diabetes researcher Charles R. “Rollo” Park, M.D., celebrated his 100th birthday on March 2 at the Heritage of Brentwood with his wife of more than 70 years, Jane Park, Ph.D., professor emerita of Molecular Physiology and Biophysics. Read MoreMar 10, 2016
-
The Conversation: Are looser gun laws changing the social fabric of Missouri?
Jonathan Metzl, director of the Center for Medicine, Health, and Society, writes: "Again and again, people with whom I spoke raised concerns, not just about the lethal potential of firearms, but about the ways that allowing guns into previously gun-free communal spaces might impact a host of commonplace civic encounters as well." Read MoreMar 10, 2016
-
Erik Carter serves as expert speaker at Congressional briefing
Changing post-school pathways of youth and young adults with severe disabilities was the focus of Erik Carter’s presentation at a Congressional briefing. Read MoreMar 9, 2016
-
Eye of a cytokine storm
A new animal model can be used to “dissect” the inflammatory response to infection. Read MoreMar 9, 2016
-
Lim’s research on evangelical activism awarded Louisville Institute grant
A Vanderbilt Divinity School professor has been awarded a grant from the Louisville Institute for his transnational study of the evangelical community's fight against human trafficking. Read MoreMar 9, 2016